Splitting Zocor tablets saves millions

	Tweet

Halving high-dose Zocor tablets leads to significant cost savings without reducing the drug’s cholesterol-lowering effects, researchers report.

Dr. David Parra from Department of Veterans Affairs Medical Center, West Palm Beach, Florida said that the findings “add to the current available research that a tablet splitting strategy for Statins is a safe and effective means to significantly reduce medication costs.”

Parra and his colleagues compared the efficacy, safety, and economics of switching patients from a whole Zocor tablet to tablets containing twice as much of the drug, but which were split in half to achieve the same dosage.

Among 1331 patients converted to split tablets, their final level of LDL ("bad") cholesterol after tablet splitting was no different from that in 2099 patients who did not switch to split tablets, the investigators report in The American Journal of Cardiology.

The annual cost of Zocor (including the cost of tablet splitters) was $211,738 in a split-tablet group of 1098 patients, compared with $339,018 for 1098 patients in a whole tablet group.

Across the VA system, the investigators point out, tablet splitting of Zocor (known generically as a simvastatin) resulted in a savings of more than $46.5 million in 2003.

According to co-author Dr. Nick P. Beckey, the average wholesale prices for simvastatin 20, 40 and 80 mg tablets are the same, and he said, “tablet splitting simvastatin—and other Statins—could result in substantial savings.”

In fact, his colleague Roy W. Coakley concluded that “physicians should be aware of the end costs of their prescribing, and if they can make it less costly for a patient with a specific drug—by tablet splitting—they should prescribe that way.”

SOURCE: American Journal of Cardiology, June 15, 2005.

RELATED STORIES:
FDA Approves Relenza for Prevention of Seasonal Flu   Key senator vows work on diet supplement bill   New anti-inflammatory drugs increase TB risk   Roche seeking others to make Tamiflu bird flu drug   Novartis Drug Risk Seen Similar to Vioxx - FDA Staff   US approves drug for two pediatric mental disorders   “Miracle” Cancer Drug Gleevec Can be Toxic to the Heart   Cocoa-derived medicines still years away: experts   Risks of old, new diet drugs face U.S. scrutiny   Hypersensitivity Reactions to the Quadrivalent HPV Vaccine Are Rare   Vertex says drug quickly treats hepatitis C   How to Prevent Morphine ‘Tolerance’

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]